Claire Hardie

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 280 citations · Full text

The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination

Jason Gurney, Elinor Millar, Alex Dunn et al. · The Lancet Regional Health - Western Pacific · 2021 · 160 citations · Full text

Early outcomes of active surveillance for localized prostate cancer

Claire Hardie, Chris Parker, A. Norman et al. · British Journal of Urology · 2005 · 145 citations

Managing haematology and oncology patients during the <scp>COVID</scp> ‐19 pandemic: interim consensus guidance

Robert Weinkove, Zoe McQuilten, Jonathan M. Adler et al. · The Medical Journal of Australia · 2020 · 126 citations · Full text